Mechanism of action of Type 2 Sodium-Glucose Cotransporter Inhibitors: Beyond glycaemic control

"Type 2 Sodium-Glucose Cotransporter (SGLT2) Inhibitors exercise their glucose-lowering effect through the inhibition of glucose reabsorption in the kidney. However, the cardiovascular and renal effects, as well as in those of cardiac failure, seem to occur independently from the glucose–loweri...

Descripción completa

Detalles Bibliográficos
Autores Principales: Sandoval, Andrés Felipe Buitrago, Vallejo, Carlos Andrés Sánchez
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23005
https://doi.org/10.1016/j.rccar.2019.12.003